VR Logo

Oxygenta Pharmaceutical: Board Meeting Outcome for Submission Of Un-Audited Financial Results For The Quarter Ended 30Th June 2022Ref: Regulation 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015


The Board at its meeting held today i.e. Friday 12th August 2022 transacted inter-alia the following businesses:1. Financial Results:The Board approved the Un-audited Financial Results for the first quarter ended 30th June 2022. In this regard please find the enclosed:? Un-audited Financial Results of the Company for the quarter ended 30th June 2022? Limited Review Report in respect of the Un-audited Financial Results of the Company for the first quarter ended 30th June 20222. Other Corporate mattersThis is for your information and records.

Click here to view PDF